These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20061611)

  • 1. Uric acid as a CNS antioxidant.
    Bowman GL; Shannon J; Frei B; Kaye JA; Quinn JF
    J Alzheimers Dis; 2010; 19(4):1331-6. PubMed ID: 20061611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbic acid and rates of cognitive decline in Alzheimer's disease.
    Bowman GL; Dodge H; Frei B; Calabrese C; Oken BS; Kaye JA; Quinn JF
    J Alzheimers Dis; 2009; 16(1):93-8. PubMed ID: 19158425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of iron-catalyzed oxidations by attainable uric acid and ascorbic acid levels: therapeutic implications for Alzheimer's disease and late cognitive impairment.
    Waugh WH
    Gerontology; 2008; 54(4):238-43. PubMed ID: 18367828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders.
    Shu Y; Li H; Zhang L; Wang Y; Long Y; Li R; Qiu W; Lu Z; Hu X; Peng F
    Brain Behav; 2017 Jan; 7(1):e00584. PubMed ID: 28127508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?
    Ye BS; Lee WW; Ham JH; Lee JJ; Lee PH; Sohn YH;
    Eur J Neurol; 2016 May; 23(5):948-57. PubMed ID: 26917248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.
    Bowman GL; Kaye JA; Moore M; Waichunas D; Carlson NE; Quinn JF
    Neurology; 2007 May; 68(21):1809-14. PubMed ID: 17515542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid treatment after stroke modulates the Krüppel-like factor 2-VEGF-A axis to protect brain endothelial cell functions: Impact of hypertension.
    Vila E; Solé M; Masip N; Puertas-Umbert L; Amaro S; Dantas AP; Unzeta M; D'Ocon P; Planas AM; Chamorro Á; Jiménez-Altayó F
    Biochem Pharmacol; 2019 Jun; 164():115-128. PubMed ID: 30954486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis.
    Dujmovic I; Pekmezovic T; Obrenovic R; Nikolić A; Spasic M; Mostarica Stojkovic M; Drulovic J
    Clin Chem Lab Med; 2009; 47(7):848-53. PubMed ID: 19496733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidants in Alzheimer's disease-vitamin C delivery to a demanding brain.
    Quinn J; Suh J; Moore MM; Kaye J; Frei B
    J Alzheimers Dis; 2003 Aug; 5(4):309-13. PubMed ID: 14624026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.
    Lönnrot K; Metsä-Ketelä T; Molnár G; Ahonen JP; Latvala M; Peltola J; Pietilä T; Alho H
    Free Radic Biol Med; 1996; 21(2):211-7. PubMed ID: 8818636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.
    Maetzler W; Stapf AK; Schulte C; Hauser AK; Lerche S; Wurster I; Schleicher E; Melms A; Berg D
    J Alzheimers Dis; 2011; 27(1):119-26. PubMed ID: 21765209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid and late-onset Alzheimer's disease: results from the ReGAl 2.0 project.
    Boccardi V; Carino S; Marinelli E; Lapenna M; Caironi G; Bianco AR; Cecchetti R; Ruggiero C; Mecocci P;
    Aging Clin Exp Res; 2021 Feb; 33(2):361-366. PubMed ID: 32277437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of uric acid and ascorbic acid in protection against EAE.
    Spitsin SV; Scott GS; Mikheeva T; Zborek A; Kean RB; Brimer CM; Koprowski H; Hooper DC
    Free Radic Biol Med; 2002 Nov; 33(10):1363-71. PubMed ID: 12419468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between uric acid and Alzheimer's disease in elderly Jordanians.
    Al-khateeb E; Althaher A; Al-khateeb M; Al-Musawi H; Azzouqah O; Al-Shweiki S; Shafagoj Y
    J Alzheimers Dis; 2015; 44(3):859-65. PubMed ID: 25362039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid levels of uric acid in dogs and the effect of allopurinol.
    Kim P; Yaksh TL; Burnett PC; Blum MR; Sundt TM
    Brain Res; 1987 Jan; 402(1):87-92. PubMed ID: 3828791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of uric acid treatments on liver glutathione system prevent oxidative damages in experimental autoimmune encephalomyelitis mice.
    Allameh A; Maleklou N; Zargari M; Sanati MH
    Neurosci Lett; 2008 Jul; 439(1):111-5. PubMed ID: 18501514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.
    Miners JS; Kehoe PG; Love S; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2019 Sep; 11(1):81. PubMed ID: 31521199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity.
    Kean RB; Spitsin SV; Mikheeva T; Scott GS; Hooper DC
    J Immunol; 2000 Dec; 165(11):6511-8. PubMed ID: 11086092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of Uric Acid in the Emergency Treatment of Acute Ischemic Stroke.
    Llull L; Amaro S; Chamorro Á
    Curr Neurol Neurosci Rep; 2016 Jan; 16(1):4. PubMed ID: 26711273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.